The market seems to be confused. The sharp broad selloff in equities in the US has been instigated mainly by the expectations of rising interest rates. If this was the case then EML earnings will improve dramatically over time due to the $250M Float they hold which earns interest income in the US. As an example for every 1% increase in rates, that's $2.5M in additional revenue which EML shares with its partners and drops straight to the EBITDA line. EML stock should be going up, not down!
- Forums
- ASX - By Stock
- 2018: the year of the EML
The market seems to be confused. The sharp broad selloff in...
Featured News
Add EML (ASX) to my watchlist
(20min delay)
|
|||||
Last
67.0¢ |
Change
-0.040(5.63%) |
Mkt cap ! $253.4M |
Open | High | Low | Value | Volume |
70.0¢ | 70.0¢ | 66.5¢ | $1.111M | 1.635M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 109155 | 66.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
67.0¢ | 4999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 109155 | 0.665 |
10 | 178848 | 0.660 |
5 | 91592 | 0.655 |
11 | 114407 | 0.650 |
1 | 8646 | 0.645 |
Price($) | Vol. | No. |
---|---|---|
0.670 | 4999 | 1 |
0.675 | 8646 | 1 |
0.680 | 32439 | 3 |
0.685 | 9826 | 2 |
0.690 | 28646 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
EML (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online